Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK189254 in Narcolepsy
NCT00366080Phase 2Terminated
- Sponsor
- GSK
- Start
- Nov 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of GSK189254 in narcolepsy, sponsored by GSK. Started Nov 2006; status: terminated.
02
Drugs
GSK189254
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT00366080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366080.